Circulating microRNAs and PD-L1 Tumor Expression Are Associated With Survival in Advanced NSCLC Patients Treated With Immunotherapy: A Prospective Study

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-18-1981
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

P2.01-61 Body Mass Index Over Time Is Associated With Overall Survival in Advanced NSCLC Patients Treated With Immunotherapy.

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

MA04.07 MicroRNA-Based Liquid Biopsy Combines With PD-L1 Tumor Expression to Predict Response to Immunotherapy in Advance NSCLC Patients

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P3.04-13 PD-L1-Gene Expression by nCounter Correlates With PD-L1 Protein Expression in Advanced Non-Small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

MA10.05 Effect of Early Steroids Use in Advanced NSCLC Patients Treated With Immunotherapy

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

PD-1/PD-L1: A Novel Target for Immunotherapy in Patients With Advanced and Metastatic Non-Small Cell Lung Cancer

Medicinski podmladak
2018English

PD‑L1 Expression Is Associated With Advanced Non‑small Cell Lung Cancer

Oncology Letters
Cancer ResearchOncology
2016English

B7-H3 Expression in NSCLC and Its Association With B7-H4, PD-L1 and Tumor-Infiltrating Lymphocytes

Clinical Cancer Research
Cancer ResearchOncology
2017English

Predictive Factors Associated With Prolonged Survival in Patients With Advanced Non-Small-Cell Lung Cancer (NSCLC) Treated With Gefitinib

British Journal of Cancer
Cancer ResearchOncology
2007English

MA19.02 Prior Therapy and Increased Expression of PD-L1 in NSCLC Tumor Samples

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy